Kilitch Drugs (India) informs about outcome of board meeting

10 May 2017 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements), Regulations 2015, Kilitch Drugs (India) has informed that Board of Directors in their meeting held on May 9, 2017 had approved the change in designation of Syed Azizur Rahman from Non-executive Director to Executive Director (Whole Time Director) of the company with effect from May 9, 2017.

The above information is a part of company’s filings submitted to BSE.

Kilitch Drugs(India) Share Price

351.50 0.20 (0.06%)
08-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.30
Dr. Reddys Lab 1370.60
Cipla 1495.05
Lupin 2252.40
Zydus Lifesciences 981.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.